FDA Investigator

Amy Kim

Latest inspection on record: New York, United States, April 2026 · records back to 2010

BiologicsFoods & Cosmetics

FDA inspection record · Last updated July 12, 2026

Overview

  • 223 inspections across 176 sites are on record.
  • 458 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-04-29.

At a glance

Inspections

223

Sites

176

Observations

458

Career since

Jul 2010

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Lenox Hill Hospital29 Apr 2026Biologics
Massachusetts General Hospital Fertility Center3 Apr 2026Biologics
Allotex, Inc.1 Apr 2026Biologics
New York Presbyterian Hospital Weill Cornell Medical College18 Mar 2026Biologics
Give Legacy - New Jersey, LLC10 Mar 2026Biologics

Sites inspected

Lenox Hill HospitalNew York, United States1 insp.
Massachusetts General Hospital Fertility CenterBoston, United States1 insp.
Allotex, Inc.Boston, United States1 insp.
New York Presbyterian Hospital Weill Cornell Medical CollegeNew York, United States1 insp.
Give Legacy - New Jersey, LLCHoboken, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Kimberley A Ricketts8 shared
Wayne J Meyer7 shared
Valerie A Potopsingh6 shared
Frank Verni4 shared
Andrew F Cohen3 shared
Sarah A Wangseng3 shared

Full investigator report

Get the verbatim findings behind Amy Kim's 458 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators